Immediate versus deferred zidovudine (AZT) in asymptomatic or mildly symptomatic HIV infected adults.

Immediate versus deferred zidovudine (AZT) in asymptomatic or mildly symptomatic HIV infected adults.

Show other versions (1)

BACKGROUND: Zidovudine (AZT) monotherapy was the first antiretroviral drug to be tested widely. Subsequent trials in asymptomatic or early symptomatic HIV infection indicated short-term delays in disease progression with AZT, but not improved survival. OBJECTIVES: To assess the effects of immediate...

Descrición completa

Detalles Bibliográficos
Main Authors:	Darbyshire, J, Foulkes, M, Peto, R, Duncan, W, Babiker, A, Collins, R, Hughes, M, Peto, T, Walker, A
Formato:	Journal article
Idioma:	English
Publicado:	2000

Títulos similares

Immediate versus deferred zidovudine (AZT) in asymptomatic or mildly symptomatic HIV infected adults.
por: Darbyshire, J, et al.
Publicado: (2000)

Zidovudine (AZT) versus AZT plus didanosine (ddI) versus AZT plus zalcitabine (ddC) in HIV infected adults.
por: Darbyshire, J, et al.
Publicado: (2000)

Zidovudine (AZT) versus AZT plus didanosine (ddI) versus AZT plus zalcitabine (ddC) in HIV infected adults
por: Darbyshire, J, et al.
Publicado: (2000)

Zidovudine (AZT) versus AZT plus didanosine (ddI) versus AZT plus zalcitabine (ddC) in HIV infected adults.
por: Darbyshire, J, et al.
Publicado: (2000)

Immediate versus deferred zidovudine.
por: Peto, R, et al.
Publicado: (1993)

Concorde: MRC/ANRS randomised double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection. Concorde Coordinating Committee.
por: Seligmann, M, et al.
Publicado: (1994)

Long-term follow-up of randomized trials of immediate versus deferred zidovudine in symptom-free HIV infection. Joint Concorde and Opal Coordinating Committee.
por: Aboulker, J, et al.
Publicado: (1998)

Use of zidovudine.
por: Peto, T
Publicado: (1989)

The effect of various drugs on the glucuronidation of zidovudine (azidothymidine; AZT) by human liver microsomes.
por: Sim, S.M., et al.
Publicado: (1991)

A critical analysis of recent data on zidovudine therapy: use in asymptomatic HIV infection and early HIV disease, dosing and resistance issues.
por: Peto, T
Publicado: (1990)

Zidovudine (AZT) and hepatic lipid accumulation: implication of inflammation, oxidative and endoplasmic reticulum stress mediators.
por: Atrayee Banerjee, et al.
Publicado: (2013-01-01)

Determination of the melting temperature, heat of fusion, and purity analysis of different samples of zidovudine (AZT) using DSC
por: Adriano Antunes Souza Araújo, et al.
Publicado: (2010-03-01)

First line treatment of acute and chronic ATLL with zidovudine (AZT) and interferon alpha (IFN-α): haematological and molecular responses
por: Fields Paul, et al.
Publicado: (2011-06-01)

Influência da geometria da plataforma na determinação de chumbo em zidovudina (AZT) por ET AAS Influence of the platform geometry on lead determination in zidovudine (AZT) by ET AAS
por: Fátima R. Moreira, et al.
Publicado: (2002-05-01)

Zidovudine (AZT) monotherapy selects for the A360V mutation in the connection domain of HIV-1 reverse transcriptase.
por: Jessica H Brehm, et al.
Publicado: (2012-01-01)

AZT
por: Carlos Alberto Morais de Sá, et al.
Publicado: (1998-12-01)

Management of COVID-19-positive asymptomatic and mildly symptomatic children
por: G V Basavaraja, et al.
Publicado: (2020-01-01)

Issues in the design and analysis of therapeutic trials in human immunodeficiency virus infection
por: Babiker, A, et al.
Publicado: (1998)

Markers of HIV infection in the Concorde trial. Concorde Co-ordinating Committee.
por: Walker, A, et al.
Publicado: (1998)

Nevirapine/zidovudine/lamivudine has superior immunological and virological responses not reflected in clinical outcomes in a 48-week randomized comparison with abacavir/zidovudine/lamivudine in HIV-infected Ugandan adults with low CD4 cell counts.
por: Munderi, P, et al.
Publicado: (2010)

Age as a determinant of survival in HIV infection.
por: Babiker, A, et al.
Publicado: (2001)

AZT as a telomerase inhibitor
por: Daniel E Gomez, et al.
Publicado: (2012-09-01)

Conformational Study of New AZT Derivatives
por: M. T. Baumgartner, et al.
Publicado: (2000-03-01)

Psychological status of asymptomatic and mildly symptomatic patients hospitalized for COVID-19
por: Prateksha Golas, et al.
Publicado: (2021-01-01)

Immediate or deferred antiretroviral therapy for central nervous system opportunistic infections?
por: Torok, M, et al.
Publicado: (2005)

Immediate aspirin for suspected ischaemic stroke.
por: Baigent, C, et al.
Publicado: (1999)

The first, the next, and the cinematographed versions of AZT
por: Paula C. JÍMENEZ
Publicado: (2014-07-01)

The first, the next, and the cinematographed versions of AZT
por: Paula C Jimenez
Publicado: (2014-08-01)

Olfactory and Taste Dysfunction in Patients with Asymptomatic and Mildly Symptomatic COVID-19 in Korea
por: Jun Yeon Won, et al.
Publicado: (2021-03-01)

Age and Sex Differences Among Mildly Symptomatic and Asymptomatic Patients with Omicron Infection in 2022 in Shanghai, China
por: Feng C, et al.
Publicado: (2022-08-01)

Evolution of antiretroviral phenotypic and genotypic drug resistance in antiretroviral-naive HIV-1-infected children treated with abacavir/lamivudine, zidovudine/lamivudine or abacavir/zidovudine, with or without nelfinavir (the PENTA 5 trial).
por: Gibb, D, et al.
Publicado: (2002)

An unexpected evolution of symptomatic mild middle cerebral artery (MCA) stenosis: asymptomatic occlusion
por: Malferrari Giovanni, et al.
Publicado: (2011-12-01)

NEUROTOXIC EFFECTS OF AZT ON DEVELOPING AND ADULT NEUROGENESIS
por: Meryem eDemir, et al.
Publicado: (2015-03-01)

Lamivudine/abacavir maintains virological superiority over zidovudine/lamivudine and zidovudine/abacavir beyond 5 years in children.
por: Green, H, et al.
Publicado: (2007)

Immediate versus Deferred Stenting for Patients Undergoing Primary Percutaneous Coronary Intervention
por: Ahmed Almorsy, et al.
Publicado: (2021-10-01)

Antibody responses after COVID-19 infection in patients who are mildly symptomatic or asymptomatic in Bangladesh
por: Tahmina Shirin, et al.
Publicado: (2020-12-01)

RNA sequence analysis of nasopharyngeal swabs from asymptomatic and mildly symptomatic patients with COVID-19
por: Miftahul Faridl, et al.
Publicado: (2022-09-01)

Community Treatment Centers for Isolation of Asymptomatic and Mildly Symptomatic Patients with Coronavirus Disease, South Korea
por: Won Suk Choi, et al.
Publicado: (2020-10-01)

Viral RNA Load in Mildly Symptomatic and Asymptomatic Children with COVID-19, Seoul, South Korea
por: Mi Seon Han, et al.
Publicado: (2020-10-01)

„A különszám azt bizonyítja, hogy jól dolgoztunk”
por: Balázs Sárvári, et al.
Publicado: (2020-08-01)